A systematic review and meta-analysis suggested that untreated white coat hypertension (WCH, isolated elevated office blood pressure [BP]), but not treated white coat effect (WCE, treated WCH), is associated with an increased risk for cardiovascular events and all-cause mortality. The analysis included 27 observational studies, comprising 25 786 participants with untreated WCH or treated WCE and 38 487 with normal BP followed for a mean of 3 to 19 years. Compared with normotension, untreated WCH was associated with an increased risk for cardiovascular events (hazard ratio [HR], 1.36), all-cause mortality (HR, 1.33), and cardiovascular mortality (HR, 2.09); the risk of WCH was attenuated in studies that included stroke in the definition of cardiovascular events (HR, 1.26). No significant increased risk was found with treated WCE. The findings persisted across several sensitivity analyses although are not consistent with several early studies. The analysis supports guidelines recommending out-of-office BP monitoring. Source: https://annals.org/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.